Search
Climb Bio Inc
CLYMAdd to Watchlist
10.360USD
-0.510-4.69%
Close 11-13 16:00（ET）
595.08MMarket Cap
LossP/E TTM
Today
-4.69%
5 Days
+0.68%
1 Month
+0.68%
6 Months
-8.56%
Year to Date
+159.00%
1 Year
+445.26%
Key Figures
10.760Open
10.990High
59.94KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
10.870Prev. Close
10.185Low
624.32KTurnover
LossP/E Static
2.61P/B
0.00%Div Yield TTM
-29.90%ROA
18.33052wk High
0.04Volume Ratio
-73.90MNet Profit
57.44MShares
-0.7757EPS TTM
0.10Beta
-30.92%ROE
1.63552wk Low
18.17%Amplitude
--Gross Margin
595.08MMarket Cap
5.62Reward/Risk
6.15%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Climb Bio Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.18/-0.20
Revenue / Forecast
--/0.00
Climb Bio Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCLYM
Number of employees17
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| RA Capital Management, LP | 19.74% |
| Pontifax Venture Capital | 9.09% |
| MPM BioImpact LLC | 4.67% |
| T. Rowe Price Associates, Inc. | 3.36% |
| Shareholder Types | Proportion |
|---|---|
| Venture Capital | 28.89% |
| Hedge Fund | 14.53% |
| Investment Advisor | 10.51% |
| Investment Advisor/Hedge Fund | 7.74% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of Climb Bio Inc (CLYM)?
The current price of Climb Bio Inc (CLYM) is 10.36.
What is the symbol of Climb Bio Inc?
The ticker symbol of Climb Bio Inc is CLYM.
What is the 52-week high of Climb Bio Inc?
The 52-week high of Climb Bio Inc is 18.33.
What is the 52-week low of Climb Bio Inc?
The 52-week low of Climb Bio Inc is 1.64.
What is the market capitalization of Climb Bio Inc?
The market capitalization of Climb Bio Inc is 595.08M.
Is Climb Bio Inc (CLYM) currently rated as Buy, Hold, or Sell?
According to analysts, Climb Bio Inc (CLYM) has an overall rating of STRONG BUY, with a price target of 27.87.
What is the Earnings Per Share (EPS TTM) of Climb Bio Inc (CLYM)?
The Earnings Per Share (EPS TTM) of Climb Bio Inc (CLYM) is -0.78.